Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,109,163
- Total 13F shares
- 1,239
- Share change
- -5,517
- Total reported value
- $89,175
- Price per share
- $72.00
- Number of holders
- 8
- Value change
- -$236,383
- Number of buys
- 4
- Number of sells
- 3
Report period
Q1 2026
Institutions
8
Top holders
8
NKTR full security history
Previous quarter: Q4 2025
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
15%
|
4,303,188
|
$331,302,473 | +$97,502,292 | 31 Mar 2026 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
9.8%
|
2,852,698
|
$205,394,256 | $0 | 31 Mar 2026 | |
| Two Seas Capital LP |
13D/G
13F
|
Company |
6.8%
|
1,959,178
|
$144,979,172 | $0 | 31 Mar 2026 | |
| SUSQUEHANNA SECURITIES, LLC |
13D/G
|
G1 Execution Services, LLC |
4%
|
809,967
|
$34,245,405 | -$18,006,925 | 31 Dec 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13D/G
|
— |
3.6%
|
6,650,000
|
$4,921,000 | $0 | 31 Dec 2024 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
3%
|
570,994
|
$32,489,559 | -$20,590,346 | 30 Sep 2025 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
2.2%
|
418,522
|
$23,813,902 | -$16,571,499 | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.6%
from 13D/G
|
645,607
|
$27,296,262 | — | 31 Dec 2025 | |
| Deep Track Capital, LP |
3/4/5
13D/G
|
10%+ Owner |
1.1%
from 13D/G
|
18,344,000
|
$32,635,810 | — | 10 May 2024 | |
| BVF INC/IL |
13F
|
Company |
5.4%
|
1,559,595
|
$65,939,677 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
1,027,089
|
$43,425,322 | — | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.1%
|
596,000
|
$25,198,880 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
566,421
|
$23,948,280 | — | 31 Dec 2025 | |
| Prosight Management, LP |
13F
|
Company |
1.9%
|
554,633
|
$23,449,883 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.6%
|
473,014
|
$19,999,032 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.6%
|
468,159
|
$19,793,774 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.6%
|
454,075
|
$19,198,291 | — | 31 Dec 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.5%
|
438,630
|
$18,545,276 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.5%
|
433,419
|
$18,324,955 | — | 31 Dec 2025 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.3%
|
384,342
|
$16,249,980 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.3%
|
383,310
|
$16,206,346 | — | 31 Dec 2025 | |
| 22NW, LP |
13F
|
Company |
1.2%
|
331,115
|
$13,999,542 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.1%
|
323,915
|
$13,695,126 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
309,777
|
$13,097,371 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.1%
|
308,414
|
$13,039,744 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1%
|
295,716
|
$12,502,872 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
1%
|
287,561
|
$12,158,079 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.98%
|
282,021
|
$11,923,848 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.98%
|
280,150
|
$11,844,742 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.89%
|
254,361
|
$10,757,656 | — | 31 Dec 2025 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.88%
|
253,125
|
$10,702,125 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.76%
|
218,337
|
$9,231,289 | — | 31 Dec 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.73%
|
210,732
|
$8,909,749 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.73%
|
210,298
|
$8,891,399 | — | 31 Dec 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.73%
|
208,302
|
$8,807,009 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.68%
|
195,656
|
$8,272,336 | — | 31 Dec 2025 | |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. |
13F
|
Company |
0.66%
|
188,112
|
$7,953,375 | — | 31 Dec 2025 | |
| Creek Drive Management Group LLC |
13F
|
Company |
0.65%
|
185,500
|
$7,842,940 | — | 31 Dec 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.62%
|
178,274
|
$7,537,425 | — | 31 Dec 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.6%
|
173,443
|
$7,333,000 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.6%
|
172,881
|
$7,309,409 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.53%
|
150,804
|
$6,375,993 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.52%
|
147,793
|
$6,248,688 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.42%
|
120,380
|
$5,089,666 | — | 31 Dec 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.39%
|
111,900
|
$4,731,132 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.36%
|
104,000
|
$4,397,120 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.35%
|
101,166
|
$4,277,298 | — | 31 Dec 2025 | |
| ING GROEP NV |
13F
|
Company |
0.35%
|
100,000
|
$4,228,000 | — | 31 Dec 2025 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.33%
|
94,134
|
$3,979,986 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.32%
|
90,743
|
$3,836,614 | — | 31 Dec 2025 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q1 2026
As of 31 Mar 2026,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,239 shares.
The largest 8 holders included
Parallel Advisors, LLC, EverSource Wealth Advisors, LLC, HOLLENCREST CAPITAL MANAGEMENT, Fortitude Family Office, LLC, TWIN PEAKS WEALTH ADVISORS, LLC, Root Financial Partners, LLC, LRI Investments, LLC, and Farther Finance Advisors, LLC.
This page lists
8
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
6
Q1 2026 holders
8
Holder diff
2
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.